EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database

An-Yi Song, Lan Mu, Xiao-Yong Dai, Li-Jun Wang, Lai-Qiang Huang

Chinese Medical Sciences Journal · 2023-03 · 38 (1) · 20-28

DOI: 10.24920/004148 ↗

At a glance

Journal article in Chinese Medical Sciences Journal, 2023-03. Written by An-Yi Song and 4 co-authors. Institution: The Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Tsinghua-Berkeley Shenzhen Institute (TBSI),…. Major MEDLINE topics: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Cited 2 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To screen antigen targets for immunotherapy by analyzing over-expressed genes, and to identify significant pathways and molecular mechanisms in esophageal cancer by using bioinformatic methods such as enrichment analysis, protein-protein interaction (PPI) network, and survival analysis based on the Gene Expression Omnibus (GEO) database.

Methods

By screening with highly expressed genes, we mainly analyzed proteins MUC13 and EPCAM with transmembrane domain and antigen epitope from TMHMM and IEDB websites. Significant genes and pathways associated with the pathogenesis of esophageal cancer were identified using enrichment analysis, PPI network, and survival analysis. Several software and platforms including Prism 8, R language, Cytoscape, DAVID, STRING, and GEPIA platform were used in the search and/or figure creation.

Results

Genes MUC13 and EPCAM were over-expressed with several antigen epitopes in esophageal squamous cell carcinoma (ESCC) tissue. Enrichment analysis revealed that the process of keratinization was focused and a series of genes were related with the development of esophageal cancer. Four genes including ALDH3A1, C2, SLC6A1,and ZBTB7C were screened with significant P value of survival curve.

Conclusions

Genes MUC13 and EPCAM may be promising antigen targets or biomarkers for esophageal cancer. Keratinization may greatly impact the pathogenesis of esophageal cancer. Genes ALDH3A1, C2, SLC6A1,and ZBTB7C may play important roles in the development of esophageal cancer.

Subjects

MeSH terms (MEDLINE)

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansEpithelial Cell Adhesion MoleculeGene Expression ProfilingGene Regulatory NetworksGene ExpressionGene Expression Regulation, NeoplasticIntracellular Signaling Peptides and Proteins

Author keywords

GEOantigenenrichment analysisesophageal cancersignaling pathwaysurvival curve

Substances

Epithelial Cell Adhesion MoleculeZBTB7C protein, humanIntracellular Signaling Peptides and Proteins

Authors and institutions

  • The Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua Shenzhen International Graduate School, Tsinghua University,…
  • Department of Chemistry, Tsinghua University, Beijing 100084, China.

Cite

APA

Song, A. Y., Mu, L., Dai, X. Y., Wang, L. J., & Huang, L. Q. (2023). Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database. Chinese Medical Sciences Journal, 38(1), 20-28. https://doi.org/10.24920/004148

Vancouver

Song AY, Mu L, Dai XY, Wang LJ, Huang LQ. Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database. Chinese Medical Sciences Journal. 2023;38(1):20-28. doi:10.24920/004148

BibTeX
@article{Song2023,
  author = {Song, An-Yi and Mu, Lan and Dai, Xiao-Yong and Wang, Li-Jun and Huang, Lai-Qiang},
  title = {Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database},
  journal = {Chinese Medical Sciences Journal},
  year = {2023},
  volume = {38},
  number = {1},
  pages = {20--28},
  doi = {10.24920/004148}
}
Start for free →